Who is sponsoring NCT04761081?

NCT04761081 is sponsored by Loughborough University.

What drugs are being tested in NCT04761081?

Interventions in NCT04761081: Habitual physical activity assessment.

What condition does NCT04761081 study?

NCT04761081 studies Physical Activity, Central Obesity, Inflammation.

Is NCT04761081 still recruiting?

NCT04761081 is currently completed. Last updated 8 April 2022.

Last reviewed 2022-04-08 · How we verify

NCT04761081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Physical Activity, Obesity, and Ethnicity Associated With the Tethering and Migration of Pro-inflammatory Monocytes?

Completed Last updated 8 April 2022

What this trial tests

trial testing Habitual physical activity assessment in Physical Activity in 40 participants. Completed in 1 February 2022.

Timeline

1 March 2021

Primary endpoint
1 August 2021

1 February 2022

Quick facts

Lead sponsor	Loughborough University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 March 2021
Primary completion	1 August 2021
Estimated completion	1 February 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Habitual physical activity assessment

Conditions studied

Physical Activity — all drugs for Physical Activity →
Central Obesity — all drugs for Central Obesity →
Inflammation — all drugs for Inflammation →

Sponsor

Loughborough University

Who can join

Adults 18 to 60, male only, with Physical Activity or Central Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Being south Asian or centrally obese may be associated with an increased risk of inflammation. The investigators are seeking to investigate whether this is the case by recruiting white European and south Asian men who are lean or have central obesity. Further, the investigators wish to investigate whether physical activity influences the associations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adipose inflammation: South Asian ethnicity and central obesity are independently associated with higher immune cell recruitment to adipose-specific media: A pilot study in men.
Roberts MJ, Hamrouni M, Wadley AJ, Bishop NC. · · 2023 · cited 4× · PMID 38011590 · DOI 10.14814/phy2.15883

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting

Other Loughborough University trials

Trials by the same sponsor.

NCT07510113 — Probiotic Study in Alcohol Recovery · NA · active not recruiting
NCT07504952 — Investigating the Impact of Probiotics on Wellbeing in a Community · NA · completed
NCT06682897 — Simplified Tai Chi Exercises to Improve Function in People With Chronic Ankle Instability · NA · completed
NCT06669702 — EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B) · NA · recruiting
NCT06849050 — The Influence of Acute Continuous Exercise and Adiposity on Appetite Hormones and Neural Correlates of Visual Food Cues · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04761081 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loughborough University
Last refreshed: 8 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04761081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing